The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein

Molecular and Cellular Biology

Volumn 18, Issue 2, 1998, Pages 1084-1093

  Alcalay, Myriam ^a   Tomassoni, Lucia ^a   Colombo, Emanuela ^a   Stoldt, Stephan ^a   Grignani, Francesco ^b   Fagioli, Marta ^b   Szekely, Laszlo ^c   Helin, Kristian ^a   Pelicci, Pier Giuseppe ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RETINOBLASTOMA PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMOSOME TRANSLOCATION; COMPLEX FORMATION; GENE CLUSTER; GROWTH INHIBITION; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; VIRUS INFECTION;

EID: 0031929684     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.2.1084     Document Type: Article

References (72)

1. Alcalay, M., D. Zangrilli, P. P. Pandolfi, L. Longo, A. Mencarelli, A. Giacomucci, M. Rocchi, A. Biondi, A. Rambaldi, F. Lo Coco, D. Diverio, E. Donti, F. Grignani, and P. G. Pelicci. 1991. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc. Natl. Acad. Sci. USA 88:1977-1981.
2. Ascoli, C. A., and G. G. Maul. 1991. Identification of a novel nuclear domain. J. Cell. Biol. 112:785-795.
3. Baker, S. J., S. Markowitz, E. R. Fearon, K. V. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
4. Boddy, M. N., K. Howe, L. D. Etkin, E. Solomon, and P. S. Freemont. 1996. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukemia. Oncogene 13:971-982.
5. Borden, K. L., M. N. Boddy, J. Lally, N. J. O'Reilly, S. Martin, K. Howe, E. Solomon, and P. S. Freemont. 1995. The solution structure of the RING finger domain of the promyelocytic leukemia proto-oncoprotein PML. Proc. Natl. Acad. Sci. USA 93:1602-1606.
6. Borden, K. L. B., J. Lally, S. Martin, N. J. O'Reilly, E. Solomon, and P. S. Freemont. 1996. In vivo and in vitro characterization of the B1 and B2 zinc binding domains from the acute promyelocytic leukemia proto-oncoprotein PML. Proc. Natl. Acad. Sci. USA 93:1602-1606.
7. Borrow, J., A. Goddard, D. Sheer, and E. Solomon. 1990. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577-1580.
8. Brown, D., S. Kogan, E. Lagasse, I. Weissman, M. Alcalay, P. G. Pelicci, S. Atwater, and J. M. Bishop. 1997. A PML/RARa transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94:2551-2556.
9. Bruggemeier, U., L. Rogge, E.-L. Winnacker, and M. Beato. 1990. Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J. 9:2233-2239.
10. Carvalho, T., J. S. Seeler, K. Ohman, P. Jordan, U. Pettersson, G. Akusjarvi, M. Carmo-Fonesca, and A. Dejean. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131:45-56.
11. Chang, K. S., Y. H. Fan, M. Andreef, J. Liu, and Z. M. Mu. 1995. The PML gene encodes for a phosphoprotein associated with the nuclear matrix. Blood 85:3646-3653.
12. Chelby-Alix, M. K., L. Pelicano, F. Quignon, M. H. M. Koken, L. Venturini, Stadler, M., J. Pavlovic, L. Degos, and H. de Thè. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9:2027-2033.
13. Chen, P. L., D. J. Riley, Y. Chen, and W. H. Lee. 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:2794-2804.
14. DeCaprio, J. A., J. W. Ludlow, J. Figge, J. Shew, C.-M. Huang, W.-H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
15. Desbois, C., R. Rousset, F. Bantignies, and P. Jalinot. 1996. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science 273:951-953.
16. de Thè, H., C. Chomienne, M. Lanotte, L. Degos, and A. Dejean. 1990. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347:558-561.
17. de Thè, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARa fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
18. Doucas, V., A. M. Ishov, A. Romo, H. Juguilon, M. D. Weitzman, R. M. Evans, and G. G. Maul. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:196-207.
19. Dyck, J. A., G. G. Maul, W. H. Miller, J. Don Chen, A. Kakizuka, and R. M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
20. Dyson, N., M. Dembski, A. Fattaey, C. Ngwu, M. Ewen, and K. Helin. 1993. Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J. Virol. 67:7641-7647.
21. Everett, R. D., and G. G. Maul. 1994. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13:5062-5069.
22. Fagioli, M., M. Alcalay, P. P. Pandolfi, L. Venturini, A. Mencarelli, A. Simeone, D. Acampora, F. Grignani, and P. G. Pelicci. 1992. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7:1083-1091.
23. Fagioli, M., M. Alcalay, L. Tomassoni, P. F. Ferrucci, A. Mencarelli, D. Riganelli, F. Grignani, T. Pozzan, I. Nicoletti, F. Grignani, and P. G. Pelicci. Cooperation between the RING+B1+B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene, in press.
24. Fattaey, A. R., E. Harlow, and K. Helin. 1993. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol. 13:7267-7277.
25. Ferrucci, P. F., F. Grignani, M. Fagioli, F. Grignani, I. Nicoletti, and P. G. Pelicci. 1997. Cell death induction by the acute promyelocytic leukemia specific PML/RARa fusion protein. Proc. Natl. Acad. Sci. USA 94:10901-10906.
26. Flenghi, L., M. Fagioli, L. Tomassoni, S. Pileri, M. Gambacorta, R. Pacini, F. Grignani, T. Casini, P. F. Ferrucci, M. F. Martelli, P. G. Pelicci, and B. Falini. 1995. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85:1871-1880.
27. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
28. Grignani, F., M. Fagioli, M. Alcalay, L. Longo, P. P. Pandolfi, E. Donti, A. Biondi, F. Lo Coco, F. Grignani, and P. G. Pelicci. 1994. Acute promyelocytic leukemia: from genetics to treatment. Blood 83:10-25.
29. Grignani, F., P. F. Ferrucci, U. Testa, G. Talamo, M. Fagioli, M. Alcalay, A. Mencarelli, F. Grignani, C. Peschle, I. Nicoletti, and P. G. Pelicci. 1993. The acute promyelocytic leukaemia specific PML/RARa fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423-431.
30. Grignani, F., U. Testa, D. Riganelli, P. F. Ferrucci, P. Samoggia, A. Pinto, D. Aldinucci, V. Gelmetti, M. Fagioli, M. Alcalay, J. Seeler, F. Grignani, I. Nicoletti, C. Peschle, and P. G. Pelicci. 1996. Effects on differentiation by the promyelocytic leukemia PML/RARa protein depend on the fusion of the PML protein-dimerization and RARa DNA binding domains. EMBO J. 15:4949-4958.
31. Grisolano, J. L., R. L. Wesselschmidt, P. G. Pelicci, and T. J. Ley. 1997. Altered myeloid development and acute leukemia in transgenic mice expressing PML/RARa under control of Cathepsin G regulatory sequences. Blood 89:376-387.
32. Gu, W., J. W. Scneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
33. Guiochon-Mantel, A., J. F. Savouret, F. Quignon, K. Delabre, E. Milgrom, and H. De Thè. 1995. Effect of PML and PML/RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 9:1791-1803.
34. Helin, K., E. Harlow, and A. R. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501-6508.
35. Hu, Q., C. Bautista, G. Edwards, D. Defeo-Jones, R. Jones, and E. Harlow. 1991. Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol. Cell. Biol. 11:5792-5799.
36. Hu, Q. J., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147-1155.
37. Huang, H.-J. S., N.-P. Wang, B. Y. Tseng, W.-H. Lee, and E. Y.-H. P. Lee. 1990. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J. 9:1815-1822.
38. Jiang, W.-Q., L. Szekely, V. Wendel-Hansen, N. Ringertz, G. Klein, and A. Rosen. 1991. Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp. Cell Res. 197:314-318.
39. Kaelin, W. G. J., M. E. Ewen, and D. M. Livingston. 1990. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10:3761-3769.
40. Kaelin, W. G. J., D. C. Pallas, J. A. De Caprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 54:521-532.
41. Kakizuka, A., W. H. J. Miller, K. Umesono, R. P. J. Warrel, S. R. Frankel, V. V. V. S. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML. Cell 66:663-674.
42. Kastner, P., A. Perez, Y. Lutz, C. Rochette-Egly, M. P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon. 1992. Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11:629-642.
43. Kelly, C., R. Van Driel, and G. W. Wilkinson. 1995. Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J. Gen. Virol. 76:2887-2893.
44. Kim, S. J., U. S. Onwuta, Y. I. Lee, L. R., M. R. Botchan, and P. D. Robbins. 1992. The retinoblastoma gene product regulates Sp-1-mediated transcription. Mol. Cell. Biol. 12:2455-2463.
45. Koken, M. H. M., F. Puvio-Dutilleul, M. C. Guillemin, A. Viron, G. Cruz-Linares, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, and H. de Thè. 1994. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 14:1073-1083.
46. Lavau, C., A. Marchio, M. Fagioli, J. Jansen, B. Falini, P. Lebon, F. Grosveld, P. P. Pandolfi, P. G. Pelicci, and A. Dejean. 1995. The acute promyelocytic leukemia-associated PML gene is induced by interferon. Oncogene 11:871-876.
47. Lee, E. Y., S. S. Yuan, L. A. Cox, A. Bradley, W. H. Lee, and K. Helin. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8:2008-2021.
48. Lee, W.-H., J.-Y. Shew, F. D. Hong, T. W. Sery, L. A. Donoso, L. J. Young, R. Bookstein, and E. Y.-H. P. Lee. 1987. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329:642-645.
49. Liu, J. H., Z. M. Mu, and K. S. Chang. 1995. PML suppresses oncogenic transformation of NIH/3T3 cells activated by neu. J. Exp. Med. 1815:1965-1973.
50. Lovering, R., I. M. Hanson, K. L. B. Borden, S. Martin, N. J. O'Reilly, G. I. Evan, D. Rahman, D. J. C. Pappin, J. Trowsdale, and P. Freemont. 1993. Identification and preliminary characterization of a protein motif related to the zinc finger. Proc. Natl. Acad. Sci. USA 90:2112-2116.
51. Mancini, M. A., B. Shan, J. A. Nickerson, S. Penman, and W. H. Lee. 1994. The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc. Natl. Acad. Sci. USA 91:418-422.
52. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
53. Miesfeld, R., S. Rusconi, P. J. Godowski, B. A. Maler, S. Okret, A. C. Wilkstrom, J. A. Gustaffson, and K. R. Yamamoto. 1986. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 46:389-399.
54. Mittnacht, S., and R. A. Weinberg. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381-393.
55. Mu, Z.-M., K.-V. Chin, J.-H. Liu, G. Lozano, and K.-S. Chang. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14:6858-6867.
56. Muchardt, C., and M. Yaniv. 1993. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 12:4279-4290.
57. Pandolfi, P. P., M. Alcalay, M. Fagioli, D. Zangrilli, A. Mencarelli, D. Diverio, A. Biondi, F. Lo Coco, A. Rambaldi, F. Grignani, C. Rochette-Egly, M.-P. Gaube, P. Chambon, and P. G. Pelicci. 1992. Genomic variability and alternative splicing generate multiple PML/RARa transcripts that encode aberrant PML proteins and PML/RARa isoforms in acute promyelocytic leukemia. EMBO J. 11:1397-1407.
58. Pandolfi, P. P., F. Grignani, M. Alcalay, A. Mencarelli, A. Biondi, F. Lo Coco, F. Grignani, and P. G. Pelicci. 1991. Structure and origin of the acute promyelocytic leukemia myl/RARa cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285-1292.
59. Perez, A., P. Kastner, S. Sethi, Y. Lutz, C. Reibel, and P. Chambon. 1993. PMLRAR homodimers: distinct DNA binding properties and heterodimeric interaction with RXR. EMBO J. 12:3171-3182.
60. Qin, X.-Q., T. Chittenden, D. Livingston, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
61. Reddy, B. A., L. D. Etkin, and P. S. Freemont. 1992. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17:344-345.
62. Richon, V. M., R. A. Rifkind, and P. A. Marks. 1992. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:413-420.
63. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
64. Seed, B., and J. Y. Sheed. 1988. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67:271.
65. Singh, P., J. Coe, and W. Hong. 1995. A role for the retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374:562-565.
66. Szekely, L., K. Pokrovskaja, W. G. Jiang, H. de Thè, N. Ringertz, and G. Klein. 1996. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol. 70:2562-2568.
67. Szekely, L., E. Uzvolgyi, W.-Q. Jiang, M. Durko, K. G. Wiman, G. Klein, and J. Sumegi. 1991. Subcellular localization of the retinoblastoma protein. Cell Growth Differ. 2:287-295.
68. Szostecki, C., H. H. Guldner, U. J. Netter, and H. Will. 1990. Isolation and characterization of a cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145:4338-4347.
69. Uvadia, A. J., K. T. Rogers, P. D. R. Higgins, Y. Murata, K. H. Martin, P. A. Humphrey, and J. M. Horowitz. 1993. Sp-1 binds promoter elements regulated by the pRB protein and Sp-1 mediated transcription is stimulated by pRB coexpression. Proc. Natl. Acad. Sci. USA 90:3265-3269.
70. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
71. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RARa in acute promyelocytic leukemia cells. Cell 76: 345-358.
72. Wessely, O., E. M. Deiner, H. Beug, and M. von Lindern. 1997. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J. 16:267-280.